This greater DNA damage translated to greater cell kill in vitro and increased anti-tumor effects in vivo, as demonstrated by the outcome of combining the DNA-PK inhibitor with Top2 poisons in clonogenic survival and tumor growth delay assays. This evidence concerns the gene TOP2A and neoplasm.